Recent Articles
Drugmaker Endo Stops Selling Opioid Opana Due to Widespread Abuse
By
Karl Utermohlen, InvestorPlace Writer
Endo has announced that it will stop selling opioid painkiller Opana due to the drug's role in the ongoing opioid abuse epidemic in the U.S.
Amazon Prime Hits 85 Million Members Milestone
By
Karl Utermohlen, InvestorPlace Writer
Amazon Prime (AMZN) continues to grow as it has now hit the 85-million member milestone. Prime membership has grown 35% over the last year.
Alphabet’s X to Launch New Geothermal Energy Company
By
Karl Utermohlen, InvestorPlace Writer
Alphabet's "moonshot" division X announced that it will launch a new geothermal energy company. Here's what you should know about Dandelion.
Why AVEO Pharmaceuticals, Inc. (AVEO) Stock Is Soaring Today
By
Karl Utermohlen, InvestorPlace Writer
Aveo Pharmaceuticals (AVEO) shares rose as the company's latest cancer drug is set to be approved in Europe sometime over the coming months.
3 Stocks to Watch on Friday: Apple Inc. (AAPL), Mondelez International Inc (MDLZ) and Synchronoss Technologies, Inc. (SNCR)
By
Karl Utermohlen, InvestorPlace Writer
Apple (AAPL) faces infringement suit, Mondelez (MDLZ) revenues will dip on cyberattack and Synchronoss Technologies (SNCR) may sell itself.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
